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mated coronary artery disease and reprddurihk exrrciw. 
emia threshold II mm ST regment dapr&+m) were similar 
in the :wo groups. Group II patieW hnd B longer exercise 
induced myocardial iscbemia. Thirty-five patie”& iGroup duratkn ,p < o.w, more pmnw”ced ST SegIw”, depre- 
aion Ip c 0.001, and 1 higher peak ra*e.prcsswc prod”Ft 
(p < WJtr. The extent of zwmwy artery disease, jection 
amiaburing exercise. Baseline betaendarphin plasma kv- 
eb were measured in blwd ~~mpks taken before exercise 
stress tntlng and analyzed by beta-andoqhi.l’~s-WA 
Kit-NEN ,a radktmmunoassay method,. 
Silent myosardial ischemia is common m pat~ems wth 
coronary artery disease (l-9,. Ahha@ factors wch as the 
degree and duration of ischcmia and left ventricular end- 
diastolic pressure have been correlated with the absence of 
symptoms (S,lll-I 0. tbe mechanisms underlymg stlent mjio- 
cardial ischemia are still uneaplaaed. On the other hand. it 
has been reported that pad& who do not expcricnse pain 
during myocadiai ischemia have a generally mcreased pain 
threshold compared with symptomatic patxnts (12-15). sug- 
gesting that individual differences in sensitivity to pain may 
partly explain the absence of angina m patients with silent 
ischemia. Among a large number of endogenous ubstances 
involved in pain modulation. beta.endorphins are believed [II 
play an important role 116-20,. To define the factors that may 
be responbable for the perception of pain in patieots with 
coronary artery disease. the besal plasma beta-endorphm 
levels I” patients with a history of an&h? were determmed 
.md compared with those til paoents without angina1 symp- 
I”llli. 
Methods 
Study patienti. Seventy-four consecutive male patients 
0nean age 51.1 + 7.6 years) with reproducible exercise- 
mduccd myocardial ischemia and angiographically docu- 
nented coronary artery disease were studied (Table I). 
Thirty-five patients 0oup I) had a histo:y of angina: 3Y 
pauentr U3oup II) did not report awnal sympiams. All 
pat~cnls in Group I had a positive exercise stress test 
associated with anginal symptoms; 14 of these patients had 
previous ,a6 weeks old) symptomatic mywardial infarction. 
In Group II, all patients had silent mywardial ischemia 
documented during repeated exercise strws tesling: 3 pa- 
tients were referred because of a history of syncope. 6 
palic”r\ rhowcd silcnl myucardial irchcmia during a routine 
physical cxami”ado”. IO peticnla rcporlcd exercise-induced 
fa!i$uc or dyspnea ar.d 20 pallent were referred after a 
oostmvacardial infarction cvalwalion showed exercise- 
Induced silent ivzhemia. ‘ihe acute phase of the previous 
myocardlal infarcwn was unrecognized in 8 of the 20 
padents I” L;oup II. Groups I and II were similar with 
respect to incidence of hypertension end smoking hiswry. 
Beta-endorphin plasma Iwels. To determine the plasma 
levels of beta-endorphi”. blood samples (10 ml) wcrc taken 
from all patiews between 9 and I1 AM. al rest and in 
comfm-iable cooditiona. 15 mi” before exercise stress Icst- 
mg. The samples were immediately centrifuged at 4’C and 
purified h> CIS Scp-Pack Canridges-Walers and the” ““a- 
IyLed by a bela-e”dorphi”-1’~5-KIA Kit-NEN (a radioimmu- 
“ozsay method) (?I >. Each sample web divided into two 
parts and reparz~ely analyzed by a tea” of pharmacologists 
who did not know the chnical chancterigtics of the patienls. 
To mininne methodologic problems, all delcrminnli~ns of 
beta-sndorphin levfl? included I” thl, rludy were analyzed 
using a smglc teat kil. 
Exercise stre~r testing. All lbc paticnls performed a mul- 
tistage bxycle ergomelric test in aupme poiiliun. the initial 
work load being 25 W. with subsequent stepwise increments 
of ?S W every 3 mm and a pedaling frequency of 60 rpm. A 
12 lead standard electrocardiogram \ECG) was take” before 
the PaI. cvcry minute during the wst. at the end of exercise 
and wry mm”le during rccovcry. Leads V,. V, and V, 
were cor~linuously monilored lhroughout Ihe test. Blood 
pressure was meawred with a standard sphygmonlanumcter 
at 3 min interv&. 
During the teal. the patients were asked about the occur- 
rence ofchest pain or discomforl. The rest ECG WBS normal 
in 40 patic”&; sipna oi previous myocardial infarction were 
present in 34 patients. A positive response was defined by 
hor,ron,a, or downsloping ST segment deprcscian >I mm. 
0.08 I after the J paint. Exercinc stress testing we\ Flopped 
when moderate to severe angina. dyspnea. exhaustion or ST 
segment depression >3 mm occurred. The recovery time 
was considered as the lime between the termination of 
exercix and the return of the ECG to baseline. The occur. 
rence of I mm ST segment d pression was dcfincd as the 
ischcmia threshold. 
Coronary arteriogrsphy. Arteriography was performed 
using the Sones technique I to 7 days before the study. 
Significant coronary artery disease was considered present 
when ~50% stenosis was found in a major coronary vessel. 
Patients wilh assc&,ted valvular disease, bundle branch 
block, congestive hear! faiiure. myocardial hypertrophy and 
diabetes were excluded from the study. Female patients 
were also excluded from this study because plasma levels of 
hem-endorphin may vary with the menstrual cycle 02). 
Drug therapy (calcium channel blocking agents and “i- 
vates in most of Ihe patients) was suspended 12 h before the 
test was performed. and the dose ofbeta-adrcnergic blocken 
was gradually reduced and then discontinued I week before 
stress testing. No plient was receiving digitalis. All patients 
gave informed consent. 
Statistical analysis. Data are presented as mea” values f 
SD. Statistical significance was tested using Ihe “onpaired t 
lest for independent samples. A p value <O.OS was consid- 
crcd significant. 
Results 
Betaadorphin plasma levels. The plasma levels of circu- 
lating beta-endorphin were significantly different between 
patients with anginal symptoms and those with silent myo- 
cardial ischemia. The levels were higher ir. asymptomatic 
po:ientr than in symptomatic patients (p < 0.001): the mean 
baseline plasma level of beta-endomhi” was 22.5 z! 19 &ml 
in patienis with angina and 43.7 i- i8 pgiml in asymplo&ic 
palients (p < O.WI) (Table I). 
Exercise slrew testing (Table 2). All patients with a his- 
tory of angina (Group I) showed evidence of myocardial 
ischemm in the presence of angix! symptoms during exer- 
cise. while all patients without symptoms (Group II) had 
ECG signs of myocardial ischemia. I” Group 1, the test was 
slopped because of the occurrence of moderate to severe 
angina in 30 patients: ST segment depression >3 mnr was 
associated with angina in 5 patients. In Group II, exercise 
stress testing was stopped because of ST segment depression 
>3 mm witha” chc-: ~8” in 8 patients, exhaustion in 14 
patients. dyspnea in 15 patients and complex ventricular 
arrhythmia in 2 patients There were no significant differ- 
(1 mm ST segmenl deprwion) were similar in lhs wo 
groups lp = NSI. 
Coronary artrriograpby (Table I). No r@ficanr ddier- 
ence between ihe two groups was found with re,pcct 10 thr 
extent ofcoronary artery disease. 11 Croup 1. 5 Iwtieot\ h:~d 
one vessel disease. I3 had two verse1 dicea~e and 17 had 
three vessel disease: in Group II. 6 paben!r hac1 cue vc~~el 
disease. 13 had two vcsse1 disease and 20 had .hrec YCFICI 
disease. Ejection fraction, calculated by ;he rlandard area- 
length method, and lefi vemricular end-diasclic prerrore 
showed no significant difference between the two groups 
(p = NS). 
Discussion 
It is well known that myocardial ischemta can oxor 
wohout pain (l-9). In this study, parienls with a history of 
angina did not differ from asymptomatic pabent~ with re- 
spect to he extent of coronary a&y dise&. as previously 
reported (23). Although it has been reported (8.10.24) that 
the presence of angina IS correlated with longer duntivn and 
higher degrez of ischemm, our group of asymptomatic pa- 
ticots showed more pronounced signs of isch&da withbill 
the appearance of symptoms. Asymptomatic patients also 
exercised for a longer period of time, attained B higher 
rate-presswe pmduct at peak exercise with a higher degree 
of ST depression and had a longer recovery duration time. 
On the other hand, Ihe rate-pressure product at the w.hem*a 
threshold was similar betwren the two groups. Hence. m lhn 
study, the absence ofangina did not seem to depend an a low 
degree of myocardial &hernia. as previously reported 
(12.23). This suggesta the porsibility that other factors are 
responsible for lhe presence or absence of pain during 
myocardiil ischemia. 
Role of betwndorphins in lhe absence of angina during 
isehemia. The missing link between ischemn and pm has 
been thought to be in the heart (25). and recently a modifierl 
‘*intenriry theory” for car&a c rwzptor activation acting on 
“ep&e-time patterns” baa been proposed (26). A “defective 
angina1 waminc! system*’ has also been proposed f2.12) lo 
explain the lack of symptoms during myocardlal i&hernia. 
Bela-endorphin, one of the most palent of endogcwxx 
opioidlike peptides. is believed to play an important role m 
the modulation of pain in rhe endogenous analgesic system. 
bath centrally and peripherally (16 17.271. Beta-codovhin 19 
produced by cells in the anterior and mtermcdiate pituitary 
gland (16). In add&on, B dirrete population of ncumns in 
the hypothalamus contams beta-eodorphm (27). The de- 
>xnding ~y\:cm of pain modulation extends from the frontal 
cortex sod hvoothalamus. throwh the oeiaaoeductal erav 
.an!ter m th; &al ventromedial med& and then !;th; 
donal horn (17,271. Activation of this cystem by opiates 
inhibits nociceptive dorsal horn neurons and produces anal- 
ge,ia (16.17.27). At the spinal level, the ~:omrot of noacep 
live processing is &e&d by drscend’ng pathways 0.7). 
IDEBI action of opiates (18) and local feedback (28.29). 
Moreover. ao endorphin-mediated modulalion of pain wms 
invohrd m analgesia related fo envimnmenral. af:entron and 
conditioninr factors 130.311. It is oat clear how areat the role 
of wmally~releascd beta-endorphins is as compared wnh 
that of penpheral circulating cndorphins. Decreased plasma 
Ievcls of beta-endorphin have been reported (22) in patients 
with miaraine. Some invesiirzators (32.33) ~rooose that the 
diE&.es in beta-endorphin concentral~on~ in plasma. 
cerebrospmal f uid and intersynaptic fluid may underlie the 
varying individual sensi!iv$, YI pain. 
Previous ludii. In our study. sigoificanlly higher base- 
line beta-endorphin plasma levels were found in patients 
wilhoul a history of angina compared with symptomatic 
patients. To date. the data from various studies are con- 
flicting with regard to Ihe relalion between beta-endorphin 
plasma levels and silent myocardiai irchemia. Akd et al. 134) 
reported that analgesia induced by stimulation of periaquc- 
ductal gray matter in the rat could be panially blo’ ‘ted by 
~oalox ,nc. a specific opiaid amagonist. Various studies have 
also heen previously carried om on the effectr of naloxone 
on sdeot myocxdial irchemia: Van Rjin and Rahkin (35) 
reported that naloxone administration 12 mg intravenously) 
during erercne-inked myoca~dial irchcmi.l. The& con- 
Rtcrmg rcsuI~\ could hc due 10 diRerent or mad:qualc doses. 
o, boib. of naloxonc used by Ihc various invesligators 
becsuw of !bc posribilily that there are individual ddTer- 
beta-endorphin levels in palicnts with coronary .ulery dis- 
cast. Weidmperet al. (371 did no! find sicnificant d.fferences 
pat,cmr, hut invead compared palicnts with coronary a,kry 
dwase with normal rubjcc:s Icontrol g,oupl. In then d,aup 
of IO palicnlz who were arymplomalic during the exfrcire 
tcs1. 5 had a historv of aneird. Is contrast. Shcos CI al. (191 
frcquendy fw:nd in GUI &up of arymptomalic palients. 
Indeed. our data succest lbal higher baseline beta-endomiun 

